Home/ReCode Therapeutics/David Lockhart, Ph.D.

DL

David Lockhart, Ph.D.

CEO

ReCode Therapeutics

Therapeutic Areas

Respiratory Metabolic Genetics & Genomics

Leadership Team at ReCode Therapeutics

Sheila Gujrathi, M.D.

Chief Development Officer

View full ReCode Therapeutics profile